Huai Lue An
Director/Board Member bij Guizhou Kekai Pharmaceutical Co., Ltd.
Vermogen: 52 M $ op 31-03-2024
Profiel
Huai Lue An is currently a Director at Guizhou Kekai Pharmaceutical Co., Ltd.
Previously, he worked as a Chairman at Guizhou Xinbang Pharmaceutical Co., Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-09-2023 | 98 057 908 ( 86.31% ) | 52 M $ | 31-03-2024 | |
| 10-07-2023 | 670 ( 0.00% ) | 353 $ | 31-03-2024 |
Actieve functies van Huai Lue An
| Bedrijven | Functie | Begin |
|---|---|---|
Guizhou Kekai Pharmaceutical Co., Ltd.
 Guizhou Kekai Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Guizhou Xinbang Pharmaceutical Co., Ltd., Guizhou Kekai Pharmaceutical Co., Ltd. is a Chinese company that wholesales pharmaceutical products. The private company is based in Guiyang, China. The company was founded in 1995. Xue Feng Gu has been the CEO of the company since 2016. Guizhou Kekai Pharmaceutical Co. was acquired by Guizhou Xinbang Pharmaceutical Co., Ltd. on March 14, 2014 for $456.24 million. | Director/Board Member | - |
Eerdere bekende functies van Huai Lue An
| Bedrijven | Functie | Einde |
|---|---|---|
| GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. | Chairman | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Guizhou Kekai Pharmaceutical Co., Ltd.
Guizhou Kekai Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Part of Guizhou Xinbang Pharmaceutical Co., Ltd., Guizhou Kekai Pharmaceutical Co., Ltd. is a Chinese company that wholesales pharmaceutical products. The private company is based in Guiyang, China. The company was founded in 1995. Xue Feng Gu has been the CEO of the company since 2016. Guizhou Kekai Pharmaceutical Co. was acquired by Guizhou Xinbang Pharmaceutical Co., Ltd. on March 14, 2014 for $456.24 million. | Distribution Services |
